Surgical Resident’s Research Challenges Dogma of Small Bowel Obstruction Management

A potentially practice-changing study led by a PSI Foundation-funded surgical resident has challenged long-held beliefs about care for small bowel obstructions (SBOs).

SBO, a blockage in the intestine often cause by scar tissue (or “adhesions”) from previous surgery, is a common condition, representing about 20% of all hospital admissions for abdominal pain. A small number of patients whose conditions don’t resolve with usual treatment receive surgery, but most patients, about 80%, recover from SBO through treatment with bowel rest, IV fluids and gastric decompression. These patients are considered to be successfully treated and released from hospital, yet many of them will return – sometimes as often as every few months – with a recurrence.

Dr. Ramy Behman, a surgical resident with the University of Toronto, wanted to study the long-term natural history of SBO and potentially improve treatment. “We’ve been treating SBO the same way for a long time. Some people bounce back from an SBO, but then they’re dealing with it every few months,” says Dr. Behman. “SBOs aren’t very well studied, so a better understanding of the natural history could be helpful to improve treatment.”

Dr. Behman applied for and received PSI Foundation funding, which he says was crucial to the research, especially so early in his career. “I don’t know how we would have done the study without the funding,” he says. “And having people outside of your research committee think that the research is worthwhile is very encouraging when you’re just starting off.”

With a Resident Research Grant, Dr. Behman looked at 10 years of health administrative data, identifying nearly 40,000 patients in Ontario admitted to hospital for their first SBO during that time period. They then followed how the patients were treated on that occasion and any following recurrences and tracked the outcomes. The large dataset allowed them to examine the different ways that SBOs are managed and how outcomes are affected.

“We were one of the first groups to really step back and look at the long-term disease course,” he says. “And what we found was challenging to the dogma.”

Physicians have long believed that surgery for SBO would increase the risk of recurrence by creating new adhesions and usually don’t recommended surgery for SBO unless other treatments are unsuccessful. But Dr. Behman’s research suggested that this actually isn’t the case – in fact, surgery could reduce the risk of recurrence. According to their results, patients with SBO treated with surgery – whether on the first or subsequent occurrences – cut the risk of recurrence by about half.

“Operating can take patients off the recurrence cycle. It can really change the trajectory of disease for patients,” says Dr. Behman.

Surgery does have its own risks, namely the risk of complications that could potentially have been avoided, as well as a greater upfront cost than standard treatment. Dr. Behman and his team are analyzing the cost-utility to examine whether the greater upfront costs are offset by fewer hospital readmissions due to recurrences, and he is hoping to publish the results soon.

He notes that the study may influence guidelines for SBO management and help physicians make informed decisions about how the condition can be managed.

“This isn’t a uniform prescription for every patient with SBO, but it adds to our understanding of the disease and facilitates informed decision making,” he says. “The optimal practice will be the right intervention for the right patient.”

Resident’s Research Identifies Barriers to Colorectal Cancer Screening in Immigrants

As the child of immigrants, Dr. Shixin (Cindy) Shen has had a long-standing interest in immigrant health issues, including cancer screening. While pursuing the Public Health and Preventive Medicine Residency at the University of Toronto, she found that there was little information about the barriers to colorectal cancer screening that immigrants in Ontario may face. “Colorectal cancer is the second most common cause of cancer, and 40% of all immigrants in Canada live in Ontario,” she says. “Yet, there wasn’t much information about colorectal cancer screening in immigrants in Ontario, despite the fact that they tend to have lower screening rates.”

To address this knowledge gap, Dr. Shen and her supervisors, Dr. Aisha Lofters and Dr. Richard Glazier, looked at the immigration and non-immigration factors that influence screening rates in immigrants, in order to get a better understanding of which are the most important.

They looked at data from a number of health care administrative databases, as well as the Immigration, Refugee and Citizenship Canada’s Permanent Resident Database, which contains records of individuals who obtained immigrant status since 1985.

Dr. Shen found that within the immigrant population there were significant differences in rates of screening non-adherence, related to different factors. Among the factors related to immigration, an individual’s region of birth and the income level of that region, as well as their immigration class (economic, family or refugee) were the most important factors that predicted screening non-adherence. Among the factors not related to immigration, individuals with no or moderate use of the health care system and those not rostered to a care team were less likely to be screened.

The results emphasize the health inequalities that immigrants may face in Ontario. “Some of these factors, especially when combined, contributed to significant disparities in screening uptake,” says Dr. Shen. “For example, among refugees from low-income countries who were not rostered and who lived in low-income areas, the rate of non-adherence to screening was 71%, compared to 25% for economic immigrants from high-income countries who were rostered and lived in high-income areas.”

The study was supported by a Resident Research Grant from PSI Foundation, which was critical for allowing the team to access the multiple databases and to support Dr. Shen’s work on the study. “The funding from PSI Foundation allowed me to lead the study from beginning to end, which was a very helpful learning experience,” she says. “I was able to further develop my skills in critical thinking, problem solving, and evidence generation, which will be helpful in my career as a public health physician.”

Dr. Shen notes that the study is just the starting point in understanding the screening barriers in this population, and that further research is needed to explore these factors in more depth. Ultimately, she hopes that the research can be used to help policymakers find ways to increase screening rates in this priority population.

“We know that screening is important for reducing cancer incidence and death rates, and we know that there are social factors that lead to poorer access to services and poorer health status,” she says. “With this research, we hope to have a better understanding of the potential causes of differential access to preventive care, so that we can address them properly and bridge the gap in health outcomes. The goal is to level the playing field so that everyone can lead healthy lives.”

Unique Early Childhood Research Group Suggests Breastfeeding Duration May Not Reduce Household Food Insecurity

Health professionals agree that breastfeeding is important for long-term child health, and it has also been suggested by policymakers as a way to reduce the risk of poverty and household food insecurity (HFI). But a recent PSI Foundation–funded study has challenged the conventional wisdom regarding breastfeeding duration and HFI, suggesting that it may be more important to focus on other strategies to reduce poverty.

“The benefits of breastfeeding are well recognized, but will it protect families from household food insecurity? Maybe not,” says Dr. Peter Wong, a pediatrician in Toronto.

Because breastmilk substitutes are expensive and could take money away from a household’s food budget, policymakers have suggested that encouraging longer duration of breastfeeding can be one way to decrease the risk of HFI. No research demonstrating the effectiveness of this strategy had previously been done, although studies have shown that the presence of HFI may adversely affect the duration of breastfeeding.

With a PSI Foundation Healthcare Research by Community Physicians grant, Dr. Wong and a team of researchers led by Drs. Patricia Parkin, Jonathon Maguire, Cory Borkhoff and Catherine Birken at TARGetKids!, a research group that focuses on early childhood health, explored this question. A unique research group in Canada, TARGetKids! includes a study population of 10,000 healthy children recruited at community-based practices to provide information about their growth, development and lifestyle to help researchers answer questions about this understudied group.

Dr. Wong and his colleagues surveyed 3,000 families from TARGetKids!, asking questions about breastfeeding duration, household food insecurity and family income. Surprisingly, they did not find an association between breastfeeding duration and HFI, suggesting that shorter duration does not increase the risk of HFI in their study population.

While Dr. Wong notes that the TARGetKids! study group provided access to a large study sample, he also says that the participants were not necessarily reflective of the population where HFI is a pressing concern, which may have influenced the results. Still, the study suggests that breastfeeding on its own may not be enough to help families struggling with poverty and HFI.

“To address household food insecurity, we need a higher level, upstream strategy that addresses more societal problems,” says Dr. Wong. “We need policies that will reduce insufficient income and poor employment. That’s where we’ll make a greater difference.”

Dr. Wong and the team are now planning to examine how breastfeeding and other health-related factors might influence measures of early childhood health, such as nutrition, development and cardiometabolic health. His primary role as a practising pediatrician, as well as his interest in community engagement, public health and epidemiology, gives him unique insight into these types of research questions. “As community physicians, we interact with families and kids on a daily basis, and we have a good appreciation for their health and social challenges,” he says. “We are able to formulate research questions that really have an impact on the health of families and communities.”

And he appreciates that PSI Foundation is supportive of physicians like him who do not have access to the same resources as academic researchers. “Full-time community clinicians have a challenging time competing in the same funding pool as academic researchers,” he says. “PSI Foundation demonstrates that physicians really do care about medical research and about asking questions that address the health of Ontarians.”

New Tool Uses Vital Sign Variability to Predict Potential of Organ Donation

Headshot of Dr. Sonny Dhanani

“PSI Foundation really looks into the needs of our patients’ and their families and the gaps in our medical practice. At PSI Foundation, where it’s physician-driven, they seem to understand what we want to do, and they understand that these ideas may not be funded elsewhere.” – Dr. Sonny Dhanani

When a new policy came into effect in Canada in 2006 that allowed organ donation after circulatory determination of death, not just neurologic determination, it unlocked the potential for many more organs to be donated. But at the same time, it created confusion in the medical community.

“The community wanted more clarity around the declaration of death related to circulatory death,” says Dr. Sonny Dhanani, an intensive care physician and researcher at the Children’s Hospital of Eastern Ontario. “When circulatory death became a way to donate organs, we needed more evidence about when and how death should be determined.”

He and his team began a small observational study, funded by PSI Foundation, that helped to provide a greater understanding of the process of circulatory death.

But just as importantly, they needed a way to predict how long a patient would live after being withdrawn from life-sustaining therapy. In the case of circulatory death, time is of the essence – organs are only viable to be transplanted for about two hours after withdrawal of life sustaining therapy, as blood flow and oxygen are depleted.

With PSI Foundation funding, Dr. Dhanani and his team looked for ways to predict how long a patient would live after removing life-sustaining therapy, with the goal that patients predicted to die within the two-hour time frame would be the best candidates for organ donation.

In their observational study of 650 patients, the team observed vital signs waveforms starting up to an hour before the patient was removed from life support and continuing up to 24 hours later. By comparing the waveform patterns and the variability of the patterns, they were able to develop a model that predicted how long an individual would live after withdrawal of life support.

They found that their model was as accurate as current clinical assessments, but has the potential to be done more efficiently, automatically and in real time. Ultimately, they hope to put all of the data together – the waveform decision tool, clinical decision tools and physicians’ assessments – to create a comprehensive prediction of whether a patient would be a good donor candidate.

“The situation right now is hard on families and the health care team. A lot of resources are mobilized for people who won’t become donors,” says Dr. Dhanani. “Our predictive tool would be personalized and done in real time, which helps to inform families about the dying process and allows the health care team to have more confidence when approaching potential families about organ donation.”

While it may seem difficult to engage families in this type of research, Dr. Dhanani and his team have always prioritized family engagement in their research, and in fact, they found high rates of participation in their studies. In their pilot study, more than 90% of the families approached consented to participate, much higher than other for other studies involving the ICU.

“If it’s felt that someone won’t die in the appropriate time frame, families aren’t even being approached to discuss donation,” says Dr. Dhanani. “That’s a missed opportunity. Our tool would help to ensure that this doesn’t occur. Everyone should have the opportunity to be a donor.”

Dr. Christopher Witiw: Focusing on the Value of Spine Surgery

Degenerative Cervical Myelopathy (DCM)

Degenerative cervical myelopathy (DCM) is the leading cause of spinal cord impairments in adults worldwide. Recent evidence indicates that surgical intervention for DCM is associated with improved function and quality of life, regardless of disease severity. Albeit effective, surgery for DCM remains costly. Moreover, wait times for spine surgery in Ontario remain lengthy and this is likely to continue as the population ages. Health policymakers require an assessment of quality and value of surgery to develop an informed decision and optimize health resource allocation.

Cost-Effectiveness of Surgery for DCM – Dr. Christopher Witiw and Dr. Michael Fehlings

Through PSI’s Resident Research funding stream, Dr. Christopher Witiw, along with his supervisor Dr. Michael G. Fehlings of Toronto Western Hospital, conducted a study to determine the cost effectiveness of surgical intervention for DCM. The investigators found that surgery provided a Headshot - Dr. Christopher Witiwsignificant improvement in quality of life and by using health economic calculations; they determined that 97.9% of interventions are very cost-effective relative to non-operative management. This finding suggests that resource allocation toward improving access to spinal surgery for those with debilitating condition is an effective allocation of resources. These findings will serve to provide surgeons and policymakers with the evidence needed to guide decision-making and optimize healthcare expenditures.

“This resident research grant, which I received from the PSI Foundation was a tremendous resource. The funding was instrumental in providing the means to combine my research training in health economics with my clinical focus on spine surgery to complete this important evaluation of the value of surgery for Degenerative Cervical Myelopathy.”

Impact of the Findings

Dr. Witiw was awarded the highly prestigious North American Spine Society Outstanding Paper Award for the manuscript based upon the findings of the study, which was published in The Spine Journal. Moreover, the data has been presented at numerous international spine surgical conferences and have been honoured with prestigious awards from a number of spinal surgical societies. Furthermore, the findings have been recently incorporated into international surgical guidelines regarding the management of Degenerative Cervical Myelopathy. Despite the success in knowledge translation to the academic spine surgery community thus far, Dr. Witiw believes more is needed to disseminate these findings to those responsible for healthcare resource allocation.

“Much of the care provided by spine surgeons is costly, but at the same time makes a tremendously positive impact on a patient’s quality of life. As healthcare resources become increasingly strained, more research pertaining to cost-effectiveness is needed to empower physicians to work with health policy makers to provide optimal care.”

Future Directions

Dr. Witiw has recently completed his neurosurgical residency training at the University of Toronto and is currently spending 1 year enrolled in a Spinal Neurosurgery Fellowship at Rush University Medical Center in Chicago. Here he is focusing on learning minimally invasive techniques for spine surgery, with the goals of lessening post-operative pain, reducing length of hospital stay and complications and optimizing outcomes. Following this, he plans to return to Toronto to a position as a spine surgeon at the University of Toronto and St. Michael’s Hospital where he hopes to continue his work on studying and improving the value of spine surgery for patients in Ontario.

Drs. Yaron Finkelstein and Suzanne Schuh: Predictors of Serious Outcomes in Infants with Bronchiolitis

Drs. Yaron Finkelstein and Suzanne Schuh’s PSI grant, BRonchiolitis Epidemiology: Air pollution and Trends of Hospitalization (The BREATH Study) was awarded in December 2014. Since then, their first manuscript, Predictors of Critical Care and Mortality in Bronchiolitis after Emergency Department Discharge, has been accepted for publication in the Journal of Pediatrics. Moreover, its critical findings led to its selection as one of the top four out of more than 3,000 abstract submissions to the annual conference of the Pediatric Academic Societies. This was presented as a platform at the American Pediatric Associations Presidential Plenary on May 7th, 2018, at the Toronto Metro Convention Centre.

Follow us on Twitter (@PSIFoundation) to stay on top of the latest news and updates.

Dr. Nav Persaud: When Advocacy Leads to Change

“A program such as this where that burden is alleviated, it does a lot more than just help you stay afloat financially. The stress that is relieved is a huge benefit. It allows you to have peace of mind. And if you have peace of mind you can build on that.” -CLEAN Meds participant

Imagine having access to a universal health care system but you are unable to treat your condition due to financial burdens. Unfortunately, Canada is one of the only advanced economies with a universal health care system that excludes universal coverage of prescription drugs.

In January 2016, PSI awarded Dr. Nav Persaud, of St. Michael’s Hospital in Toronto, the 2016 Graham Farquharson Knowledge Translation Fellowship. With a focus on addressing health inequalities, Dr. Persaud launched the CLEAN Meds project to assess how better access to life-saving medications for people with low incomes might improve health, control disease, and save Canadians billions of dollars annually.

Dr. Persaud’s recent study published in the Canadian Medical Association Journal indicates that if Canada had a national strategy for publicly funding essential medicines, patients and private drug sponsors would save $3 billion. With four hundred patients currently enrolled in the CLEAN Meds project, measuring the health effects of providing patients with free access to essential medicines who could not previously afford them will be instrumental in shaping public policy.

In May 2018, Dr. Persaud will share the results with public ddecision-makers in the hope that they will pay attention to research findings and views of Canadians to publicly fund a minimal list of essential medicines.

For more information, please click on the following links:

Program
About CLEAN Meds

Publications
Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada

Development of a preliminary essential medicines list for Canada

Media
The argument for providing ‘essential medicines’ for free in Canada

Government drug coverage could save Canadians ‘billions,’ study finds

Essential medicines must be available to all Canadians

Podcasts
Huge potential savings from public coverage of essential medicines in Canada

Dr. Mark Sinyor: Using Data to Help Fight Suicide in Toronto

“Suicide is the number one cause of death from illness from adolescence to mid-life. Unfortunately, the biggest challenge isn’t a lack of programs or services, rather it is identifying high risk groups and understanding the most effective preventative measures.” -Dr. Mark Sinyor

In 2010, Dr. Mark Sinyor of Sunnybrook Health Sciences Centre published the Bloor Viaduct study in the British Medical Journal (Link: http://www.bmj.com/content/341/bmj.c2884.full). Through this study he determined that more had to be done in Toronto to prevent suicide than just building a barrier at the Bloor Street Viaduct bridge. In 2011, PSI launched Dr. Sinyor’s independent research career by awarding him with $20,000 for his Resident Research project titled, “Understanding suicides in Toronto: a comparison of suicide victims with and without a history of suicide attempts.”

The funding was fundamental to collecting and pairing epidemiology and clinical data, which includes information from over 3000 suicides in Toronto. With this kind of information at hand, the database has been a game changer in helping to inform suicide prevention in the city. Researchers, for example, are able to correlate relationships between gender, age groups, and regions of the city with higher rates of suicide. Breaking up this kind of information allows for tailored intervention, which will be key in helping to identify mental illness among different groups, such as in socially isolated elderly or in youth. Essentially, the database is helping to detect people prone to suicide, identify how to treat them, and how to treat suicide in itself. Dr. Sinyor and the research funded by PSI were part of Toronto Public Health’s suicide prevention initiative. In 2015, he organized the first forum in Canada connecting mental health experts, public health policy makers and members of the media to discuss steps to improve public discourse about suicide. Dr. Sinyor also sits on the TTC’s suicide prevention committee.

According to Dr. Sinyor, good treatments exist; however, the community needs to take more of an initiative to recognize, understand and talk about mental illness in order for people to utilize the correct services. With better understanding, particularly in high risk areas, anyone from healthcare workers, friends, family, and teachers can create meaningful change.

If you’re interested in learning more about Dr. Sinyor’s work, please click on the following links:

 

Dr. Christopher Wallis: Does Testosterone Replacement Therapy Increase Risk of Cardiovascular Disease?

The PSIF Resident Research Grant gave me the opportunity to investigate an issue of interest both to me and the medical community. Through this support, I was able to develop an analysis which goes into greater detail than previously available. In doing so, I worked collaboratively with many researchers who would otherwise not have interacted. While the true importance of this work remains to be seen, this opportunity has greatly enriched my research experience.” – Dr. Christopher Wallis

In 2014, a controversial article published in the Journal of the American Medical Association suggested that testosterone replacement therapy increases cardiovascular risk. Dr. Christopher Wallis of the University of Toronto knew he had access to a wealth of information available in Canadian healthcare databases to address this controversy. Through the support of PSI Foundation, Dr. Wallis was awarded a Resident Research Grant for $17,500 in 2015 in order to further investigate this question in his study titled “A population-based cohort study assessing cardiovascular and oncologic events associated with testosterone replacement therapy.”

Examining all patients over the age of 65 treated with testosterone and untreated, matched patients, Dr. Wallis and colleagues were able to conclude that testosterone treatment over the long-term is associated with a decreased risk of death and cardiovascular events.

Dr. Wallis has now published these results in the Lancet Diabetes & Endocrinology and has shared this information with fellow doctors at international medical meetings and with the public through radio, print and online interviews in Canada and the United States.

While there are limitations to conclusions which can be drawn from these data, this represents an important step in our understanding as well as reassurance to patients receiving and physicians prescribing testosterone. The authors hope that these results will provide the impetus for further research understanding the mechanisms of testosterone’s effect on the cardiovascular system.

For more information, click on the following link:

Long-term treatment key to safe testosterone replacement therapy: study

Dr. Christine Lee: A Fresh Take on Poop

“Our family wants to thank you for saving the life of our one-hundred-year-old mother by treating her with a fecal transplant. Before this amazing cure, she suffered for seven months with recurring bouts of c-difficile and her health was rapidly deteriorating. She completely recovered from this debilitating disease within 24 hours of the treatment in January.” – Laurie and Jay Cashmore

When you think of poop, does lifesaving come to mind? In 2013, Dr. Christine Lee from McMaster University was awarded with $169,000 for her clinical research study “A prospective randomized double-blind trial of fresh versus frozen-and-thawed human biotherapy for recurrent Clostridium difficile infection.”

Clostridium difficile infection (CDI) occurs when the colon is stripped of good bacteria, typically due to patients taking antibiotics. The use of fresh fecal microbiota transplantation has been the common practice for treatment for recurrent CDI; however, problems related to time involved for screening process and the short window of opportunity to use the specimen have posed as a challenge.

Dr. Lee is overcoming these challenges with her research that proves the feasibility of frozen fecal versus fresh fecal in several areas:

Emotionally, there is a restoration of health and quality of life for many patients, as well as their family members who are the ones caring for the patients.

Economically, the financial burden is lifted for patients and families, as there is a high cost associated with prolonged stays and long-term use of medication (up to $30,000).

Within the healthcare industry, significant reduction in overall length of hospital stay not only minimizes the risk of transmission to other patients, but also, reduces costs. For example, in treating 150 patients over a span of 1.5 years there was a financial savings of $3.3 million.

Next steps are to offer Lyophilized, which is freeze-and-dried stool that can be sent anywhere, making it available more widely.

If you’re looking to become a donor and/or interested in more information, please do not hesitate to contact Dr. Christine Lee at clee@mcmaster.ca.

To find out more, take a look at these links:

Stay Informed

Grant and foundation updates straight to your inbox.